Computed Tomography3D SurviewNCT07267533
Precise 3D Surview
An observational study of Computed Tomography, run by Philips Clinical & Medical Affairs Global.
Trial summary
The purpose of the study is to assess the performance of Precise 3D Surview on CT 5300 and Incisive CT Scanners as compared with manual annotation by experienced CT technologists. To evaluate the acceptance rate of the Auto 3D Planning Box compared with manual annotation by experienced CT technologists. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Computed Tomography
- How many people
- 274 participants
- Where
- No sites listed yet
- Study dates
- 31 Jan 2026to 1 Oct 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults
Who may be able to join
- Subjects scanned by CT 5300 (K232491) and Incisive CT (K212441) according to the department standard of care clinical protocols.
- Subjects age is over eighteen (18) years1.
- Patients scanned in supine orientation.
- Non-contrast CT scan
- CT scan with standard resolution
Who cannot join
- Subjects age is under or equal 18 years old
- Patients are not scanned in supine orientation.
- Contrast-enhanced CT scans.
- CT scans with high resolution
- Scans that are not completed due to technical difficulties
About this study
Official title: Precise 3D Surview Clinical Study
The purpose of the study is to assess the performance of Precise 3D Surview on CT 5300 and Incisive CT Scanners as compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto 3D Planning Box compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto Suggestion for Locator compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto Planning for Truncated Anatomies (lung and liver) compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of Auto Planning and Symmetry Correction for Tilted Head compared with manual annotation by experienced CT technologists.
- Conditions
- Computed Tomography
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptance rate of the 3D Surview
Measured: Reading session at 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2025
- Study start31 Jan 2026 (estimated)
- Primary completion1 Sep 2026 (estimated)
- Study completion1 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Computed TomographyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 274 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Philips Healthcare (Suzhou) Co., Ltd.
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07267533
- Sponsor's protocol ID
- Precise 3D Surview
- Acronym
- 3D Surview
- Status last verified
- Sep 2025
- First submitted
- 23 Sep 2025
- Last updated
- 5 Dec 2025
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Precise 3D Surview Clinical Study
- ClinicalTrials.gov ID
- NCT07267533
- Acronym / sponsor ID
- 3D Surview / Precise 3D Surview
- Conditions
- Computed Tomography
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 274 participants (estimated)
- Lead sponsor
- Philips Clinical & Medical Affairs GlobalIndustry (pharma, biotech, devices)
- Collaborators
- Philips Healthcare (Suzhou) Co., Ltd.
- Study start
- 31 Jan 2026 (estimated)
- Primary completion
- 1 Sep 2026 (estimated)
- Study completion
- 1 Oct 2026 (estimated)
- First posted
- 5 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to assess the performance of Precise 3D Surview on CT 5300 and Incisive CT Scanners as compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto 3D Planning Box compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto Suggestion for Locator compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of the Auto Planning for Truncated Anatomies (lung and liver) compared with manual annotation by experienced CT technologists.
- To evaluate the acceptance rate of Auto Planning and Symmetry Correction for Tilted Head compared with manual annotation by experienced CT technologists.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults
Key inclusion criteria (5 listed)
- Subjects scanned by CT 5300 (K232491) and Incisive CT (K212441) according to the department standard of care clinical protocols.
- Subjects age is over eighteen (18) years1.
- Patients scanned in supine orientation.
- Non-contrast CT scan
- CT scan with standard resolution
Key exclusion criteria (5 listed)
- Subjects age is under or equal 18 years old
- Patients are not scanned in supine orientation.
- Contrast-enhanced CT scans.
- CT scans with high resolution
- Scans that are not completed due to technical difficulties
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Acceptance rate of the 3D Surview
Time frame: Reading session at 4 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2025.
Related trials for Computed Tomography
Not yet recruitingPhase 1/2
Alveolar Ridge Preservation (ARP) Study Using Alloplastic Biomaterial and a Resorbable Synthetic Membrane. A Digital Workflow (CBCT/Scanner) Evaluates Hard and Soft Tissue Volumetric Changes at 4 Months, Validating Support for the Gingival Phenotype and Buccal Bone Plate.
Alveolar Ridge Augmentation, Bone Substitutes
Enrolling by invitation
Comparison of Maxillary Canine Retraction Rate With and Without Power Arm
Orthodontic Anchorage, Power Arm Sliding
Active, not recruiting
Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic Coronary Syndrome
Computed Tomography Angiography, Coronary Artery Disease
RecruitingObservational study
Anatomical and Imaging Assessment of the Alveolar Antral Artery Canal Using CBCT
Maxillary Sinus, Cone-Beam Computed Tomography
RecruitingObservational study
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
Coronary Artery Disease, Plaque
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Computed Tomography, run by Philips Clinical & Medical Affairs Global.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptance rate of the 3D Surview (time frame: Reading session at 4 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025; AzTrials last refreshed its copy on 27 Oct 2026.